Patent directory · USPTO A61K / A61P
Patents matching “SION”
1,496 pharma patents match "SION" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,496 pharmaceutical patents matching "SION" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10603250
One-pack type dentinal tubule occlusion material
granted -
US 10597657
RNAi agents and compositions for inhibiting expression of apolipoprotein C-III (APOC3)
granted -
US 10597739
Probiotic bifidobacterium strain
granted -
US 10591471
Suppression of SPLA2-integrin binding for treating an inflammatory condition or suppressing cell proliferation
granted -
US 10590416
RNAi agents for inhibiting expression of alpha-ENaC and methods of use
granted -
US 10584306
Surfactant microemulsions
granted -
US 10584147
Procoagulant fusion compound
granted -
US 10577607
Modulation of DYRK1B expression
granted -
US 10577604
Methods for monitoring C9ORF72 expression
granted -
US 10577605
Induced exon inclusion in spinal muscle atrophy
granted -
US 10562930
Salts and crystal forms of GABAA positive allosteric modulator
granted -
US 10563184
Regulation of gene expression using engineered nucleases
granted -
US 10555960
Use of an aminoglycoside for nonsense mutation suppression and the treatment of disease
granted -
US 10556916
Zirconium-89 oxine complex as a cell labeling agent for positron emission tomography
granted -
US 10557137
Modulating apolipoprotein (a) expression
granted -
US 10548953
Factor VIII-XTEN fusions and uses thereof
granted -
US 10544418
RNAi inhibition of alpha-ENaC expression
granted -
US 10537560
P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
granted -
US 10538762
Allele selective inhibition of mutant C9orf72 foci expression by duplex RNAS targeting the expanded hexanucleotide repeat
granted -
US 10533040
Colon and pancreas cancer peptidomimetics
granted -
US 10533175
Compositions and methods for modulating Ataxin 3 expression
granted -
US 10525248
Apparatus and method for promoting fluid uptake into an implant
granted -
US 10517889
Modulators of SMAD7 expression
granted -
US 10517953
Modulators of PCSK9 expression
granted